Alterations of constitutive pericentromeric heterochromatin in lymphocytes of cancer patients and lymphocytes exposed to 5-azacytidine are associated with DNA hypomethylation

Experimental Oncology

Volumn 30, Issue 3, 2008, Pages 230-234

  Shvachko, L P ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

5 azacytidine; Constitutive pericentromeric heterochromatin; DNA hypomethylation; Latent polyteny

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 4',6 DIAMIDINO 2 PHENYLINDOLE; AZACITIDINE; DNA; POLYETHYLENE;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CELL CULTURE; CELL STRUCTURE; CHROMOSOME; CONSTITUTIVE HETEROCHROMATIN; CONTROLLED STUDY; DEMETHYLATION; FLUORESCENCE; GENOMICS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTERPHASE; LYMPHOCYTE; MAJOR CLINICAL STUDY; METAPHASE; METHYLATION;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CASE-CONTROL STUDIES; CENTROMERE; CHROMOSOMES, HUMAN; DNA METHYLATION; DNA, NEOPLASM; HETEROCHROMATIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; METAPHASE; NEOPLASMS; PLOIDIES;

EID: 53649096967     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jones PA, DNA methylation and cancer. Oncogene 2002;21: 5358-60.
2. Szyf M. Targeting DNA methylation in cancer. Bull Cancer 2006;93:961-72.
3. Shames DS, Minna JD, Gazdar AF, DNA methylation in health, disease, and cancer. Curr Mol Med 2007;7:85-102.
4. Feinberg AP, Vogelstein B, Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983;301: 89-92.
5. Baylin SB, Bestor TH, Altered methylation pattern in cancer cell genomes: cause or consequence? Cancer cell 2002;1: 299-305.
6. Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003;63:1114-21.
7. Baylin SB, Herman JG, DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16: 168-74.
8. Herman JG, Baylin SB, Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 2000;249:35-54.
9. Garinis GA, Patrinos GP, Spanakis NE, Menounos PG, DNA hypermethylation: when tumour suppressor genes go silent. Hum Genet 2002;111: 115-27.
10. Sherr CJ, Principles of tumor suppression. Cell 2004;116: 235-46.
11. Fraga MF, Herranz M, Espada J, et al. A Mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 2004;64: 5527-34.
12. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation - a fundamental aspect of neoplasia. Adv Cancer Res 1998, 72:141-96.
13. Wajed SA, Laird PW, DeMeester TR. DNA methylation: an alternative pathway to cancer. Ann Surg 2001;234:10-20.
14. Worm J, Guldberg P, DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy. J Oral Pathol Med 2002;31:443-9.
15. Clark SJ, Meiki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002;21:5380-7.
16. Ballestar E, Esteller M, The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications. Prog Mol Subcell Biol 2005;38: 169-81.
17. Jones PA, Baylin SB, The epigenomics of cancer. Cell 2007;128:683-92.
18. Howard G, Eiges R, Gaudet F, et al. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008;27:404-8.
19. Wilson AS, Power BE, Molloy PL, DNA hypomethylation and human diseases. Biochim Biophys Acta 2007;1775: 138-62.
20. Shvachko LP, The correlation relationships between cancer-associated pattern genome DNA hypomethylation and mitotic interphase nuclear heterochromatinization contributing to carcinogenesis. Proc Biol Med 2008;2: 38-45. (In Ukrainian).
21. Shvachko LP, Buck IG, Stepanenko AP, et al. The method of early detection of cancer. Declaration Patent of Ukraine 2006, UA 13616, Byul. No 4. (In Ukrainian).
22. Stefanova VN, Chyryacva OG, Smirnov AF, The influence of 5-azacytidine on the structure-function organization of mitotic chromosomes. IV All-Union symposium "Molecular mechanisms of genetics processes". Proceedings, Moscow, 3-6 February 1987:49. (In Russian).
23. Habcts GG, van der Kammen RA, Scholtes EH, Collard JG, Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine. Clin Exp Metastasis 1990;8: 567-77.
24. Szyf M, Pakncshan P, Rabbani SA, DNAdemethylation and cancer: therapeutic implications. Cancer Letters 2004;211: 133-43.
25. Zhimulev IF, The chromomere organization of polytene chromosomes. Novosybirsk, VO "Science" 1994: 565 p. (In Russian).
26. Chen T, Hevi S, Gay F, et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 2007;39: 391-6.
27. Momparler RL, Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine). Semin Oncol 2005;32:443-51.
28. Szyf M, Therapeutic implications of DNA methylation. Future Oncol 2005;1: 125-35.